ABH Healthcare IPO
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
IPO GMP
₹0
+0% expected gain
Price Band
₹96 - ₹102
Lot Size
2400 shares
Min Investment
₹2,44,800
Listing Date
September 1, 2026
About ABH Healthcare
Company overview, business, and key facts.
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
ABH Healthcare offers healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL, and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY). As of FY25, the firm includes 29 doctors and 137 nurses. Its competitive strengths are a professional management team, providing quality clinical care, modern equipment, and a track record of stable financial growth.
Headquarters
Firozpur, Punjab
Promoters
Kamal Baghi, Saurabh Baghi, Vaishali Saini
Website
https://www.abhhealthcare.org/
IPO Details
Subscription Status
How many times each investor category has bid for the issue.
Strengths & Risks
Strengths
- Review: Neutral
Risks
Financials
Restated summary financials for the most recent periods.
Figures are indicative and restated for presentation.
ABH Healthcare IPO Key Numbers
Calculated by IPOLyst from the published offer-document data. These are figures, not buy or sell calls.
Market cap at upper band
₹116.6 Cr
Post-IPO shares × upper price band
P/E on 2026 profit
20.7x
Peer median 26.1x (discount of 20.7%)
Price to sales
2.22x
Revenue growth, 2026
+6.6%
12.7% a year over the period
Profit growth, 2026
+5.4%
84.3% a year over the period
Profit margin (PAT)
10.7%
EBITDA margin 28.03%
ROE / ROCE
39.07% / 19.09%
As published in the offer document
Debt to equity
3.2
Issue mix
100% fresh / 0% sale
Fresh issue goes to the company, offer for sale to selling shareholders
GMP-implied gain per lot
₹0
2400 shares on ₹2,44,800. GMP is unofficial.
What stands out
- Priced at a 20.7% discount to the peer median P/E of 26.1.
Watch-outs
- Leverage: debt to equity is 3.2.
- 79.8% of the disclosed use of proceeds is debt repayment.
- 1 use-of-proceeds item(s) have no disclosed amount.
Scenarios apply today's grey market premium figures to the upper price band. They are illustrations, not predictions. GMP is unofficial and can be wrong.
Not yet available for this IPO: published risk factors.
IPO Analysis SummaryAI-generated
A plain-language review of ABH Healthcare's financials, valuation and demand, based only on the verified figures above. For information only. It does not recommend whether to apply.
ABH Healthcare IPO Review
Analysis based on live GMP, subscription, and issue details.
ABH Healthcare IPO is currently showing a neutral GMP of ₹0, suggesting the market is cautious about listing gains.
The IPO has been subscribed 1.44x overall — QIB: 8.37x, NII: 0.29x, Retail: 1.69x.
ABH Healthcare IPO subscription has closed. The shares are expected to list on September 1, 2026.
The minimum investment required is ₹2,44,800 for 2400 shares (1 lot). Retail investors can apply at cut-off price for the best chance of allotment.
Key strengths include: Review: Neutral.
Disclaimer: IPO GMP is indicative and sourced from the grey market. This is not investment advice. Please consult a SEBI-registered advisor before investing.
ABH Healthcare IPO — Frequently Asked Questions
What is ABH Healthcare IPO GMP today?
ABH Healthcare IPO GMP (grey market premium) today is ₹0, suggesting an estimated listing gain of +0%. GMP is indicative and subject to change.
What is the price band of ABH Healthcare IPO?
The price band for ABH Healthcare IPO is ₹96 - ₹102 with a lot size of 2400 shares. The minimum investment required is ₹2,44,800.
When is ABH Healthcare IPO allotment date?
ABH Healthcare IPO allotment is expected to be finalised on August 28, 2026. You can check your allotment status on the registrar's website (Bigshare Services Pvt. Ltd.) using your PAN number.
When will ABH Healthcare IPO list on NSE/BSE?
ABH Healthcare IPO is expected to list on NSE SME on September 1, 2026.
How to check ABH Healthcare IPO allotment status?
To check ABH Healthcare IPO allotment status, visit the registrar's website (Bigshare Services Pvt. Ltd.) and enter your PAN number, application number, or DP/Client ID. You can also check on the BSE IPO allotment page at https://www.bseindia.com/investors/appli_check.aspx.
Should I apply for ABH Healthcare IPO?
ABH Healthcare IPO has a GMP of ₹0. Before applying, review the company's financials, business model, issue structure (OFS vs fresh issue), and sector outlook. IPOLyst is not a SEBI-registered investment advisor — please consult a qualified financial advisor before investing.
What is the lot size of ABH Healthcare IPO?
The lot size for ABH Healthcare IPO is 2400 shares per lot. The minimum investment for retail investors is ₹2,44,800. Retail investors can apply for a maximum of 13 lots or up to ₹2 lakh, whichever is lower.